Pfizer Inc
NYSE: PFE
▼
43.79
-0.14
-0.32%
1 Day
-
Open
44.13
-
Previous Close
43.93
-
Volume (Avg)
274 (10.00M)
-
Day's Range
43.76-44.29
-
52Wk Range
33.20-44.46
-
Market Cap.
256.70B
-
Dividend Rate (Yield)
1.36 (3.11%)
-
Beta
0.97
-
Shares Outstanding
5.86B
-
P/E Ratio (EPS)
11.71 (3.74)
Top Stories
-
Pfizer facing difficult path to ramp up biosimilar business
Seeking Alpha 16 hrs agoIn an entirely predictable scenario, Pfizer (PFE-0.3%) is encountering a broad range of competitive roadblocks in its efforts to gain traction in its biosimilar business, a strategic priority ...
-
Smart Money On Johnson & Johnson Vs. Pfizer
Seeking Alpha -
Resurgent Pfizer Stock Testing 19-Year Resistance
Investopedia -
Atopic Dermatitis Drugs - Global Markets to 2022 Featuring Bayer, LEO Pharma, Mylan, Pfizer and Sanofi - ResearchAndMarkets.com
NewsOK -
CAR T-Cell Therapy Market –Competitive Analysis With major Key Players Novartis International AG, Kite Pharma, Inc., Juno Therapeutics, Pfizer
openpr.com 20 hrs ago -
Global Dietary Supplement Market Growing Rapidly by 2025 – Top Players are Pfizer, Amway, Suntory, Glanbia and Other
Medgadget -
Sickle Cell Disease Treatment Market (2018-2023) Size, Share & Trends Analysis Featuring Emmaus Life Sciences, Global Blood Therapeutics, Bluebird Bio, Pfizer, and Novartis ...
Business Wire
